ArticleNeurosurgical review2026
Results of TcMEP guided vestibular schwannoma surgery; long term follow-up and progression free survival.
Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Intraoperative neurophysiological monitoring (IONM) in neurosurgery: A critical appraisal of established practices, ongoing controversies, and future trajectories.Journal of anesthesia and translational medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In patients with large vestibular schwannomas (VS), surgery is the primary treatment despite risks such as facial nerve dysfunction. Intra-operative monitoring with transcranial motor evoked potentials (TcMEP) helps predict facial nerve outcome but may lead to subtotal resections and later recurrence. This study compares TcMEP thresholds, facial nerve outcome, recurrence rate and progression-free survival in Koos grade 4 vestibular schwannomas. Fifty-five surgically treated patients with Koos grade 4 VS (2015-2024) were included in this retrospective study. All underwent facial nerve TcMEP monitoring. House-Brackmann (HB) scores were assessed postoperatively, and at 6 weeks, 6 months and 1 year. Progression-free survival was analyzed with Kaplan-Meier curves. Postoperatively, 58% showed a decline in facial nerve function. After one year, 83% had good function (HB I-II). A TcMEP threshold increase < 20 mA correlated with good outcomes. In 84% (47/55), a small residual tumor remained (mean 0.4 cc; range 0-7.9 cc). Median growth-free survival was 76 months after subtotal resection (STR) and not reached after near-total resection (NTR). We conclude that TcMEP-guided surgery for large vestibular schwannomas provides good facial nerve outcomes, small acceptable remnants and a low long-term recurrence risk. As fewer than half of residual tumors show growth within 8 years, routine postoperative radiotherapy is not recommended; a watchful-waiting strategy is preferred.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.